Meropenem for Injection 1g/20ml
US$1.70-2.50 / vial
  • Recommend for you
  • What is 10ml 50′s/Box Sodium Chloride Injection with Shinepharm
  • What is GMP Certified Metronidazole Capsules 500mg for Reliable Infection Relief
  • What is Paracetamol/Acetaminophen Syrup/Suspension 120mg/5ml Pharmaceutical with GMP

What is 1g Meropenem for Injection, 20ml - Quality Assurance Guaranteed

About this Item
Details
Company Profile

Price

Min. Order Reference FOB Price

50000 vial US$1.70-2.50 / vial

Sepcifications

  • Application Surgery
  • Usage Mode IV
  • Suitable for Elderly, Children, Adult
  • State Solid
  • Shape Powder
  • Type Biological Products
  • Pharmaceutical Technology Chemical Synthesis
  • Transport Package 10vials/Box
  • Specification 1G/20ML
  • Trademark MEDIPHARM /SHINEPHARM
  • Origin China
  • Standard Bp/Cp
  • Documents GMP,Copp,Ctd
  • OEM/ODM Available

Product Description

MEROPENEM FOR INJECTION 1G/20ML Indications: Meronem is indicated for the treatment of the following infections in adults and children aged 3 months and older: • Severe pneumonia, including hospital and ventilator-associated pneumonia. • Broncho-pulmonary infections in cystic ...

Learn More

Meropenem for Injection 1g/20ml Comparison
Transaction Info
Price US $ 1.70-2.50/ vial US $ 0.35/ vial US $ 0.35/ vial US $ 1.65-1.70/ vial US $ 1.65-1.70/ vial
Min Order 50000 vial 100000 vial 100000 vial 30000 vial 30000 vial
Payment Terms L/C, T/T T/T T/T T/T T/T
Quality Control
Product Certification - GMP, SGS, ISO GMP, SGS, ISO GMP, ISO, SGS GMP, ISO, SGS
Management System Certification ISO 9001, GMP, ISO 13485, FSC ISO 9001, ISO 14001, OHSAS/ OHSMS 18001 ISO 9001, ISO 14001, OHSAS/ OHSMS 18001 ISO 9001, ISO 14001, OHSAS/ OHSMS 18001 ISO 9001, ISO 14001, OHSAS/ OHSMS 18001
Trade Capacity
Export Markets South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia North America, Eastern Europe, Africa, Mid East, Western Europe North America, Eastern Europe, Africa, Mid East, Western Europe North America, Eastern Europe, Africa, Mid East, Western Europe North America, Eastern Europe, Africa, Mid East, Western Europe
Annual Export Revenue US$10 Million - US$50 Million Above US$100 Million Above US$100 Million Above US$100 Million Above US$100 Million
Business Model OEM, ODM, Own Brand(Shinepharm) OEM, ODM, Own Brand(Reyoung) OEM, ODM, Own Brand(Reyoung) OEM, ODM, Own Brand(Reyoung) OEM, ODM, Own Brand(Reyoung)
Average Lead Time Off Season Lead Time: one month
Peak Season Lead Time: 1-3 months
Off Season Lead Time: one month
Peak Season Lead Time: 1-3 months
Off Season Lead Time: one month
Peak Season Lead Time: 1-3 months
Off Season Lead Time: one month
Peak Season Lead Time: 1-3 months
Off Season Lead Time: one month
Peak Season Lead Time: 1-3 months
Product Attributes
Specification
Application: Surgery;
Usage Mode: IV;
Suitable for: Elderly, Children, Adult;
State: Solid;
Shape: Powder;
Type: Biological Products;
Pharmaceutical Technology: Chemical Synthesis;
Standard: Bp/Cp;
Documents: GMP,Copp,Ctd;
OEM/ODM: Available;
Application: Internal Medicine;
Usage Mode: For external use;
Suitable for: Elderly, Children, Adult;
State: Solid;
Shape: Powder;
Type: Organic Chemicals;
Pharmaceutical Technology: Chemical Synthesis;
Drug Reg./Approval No.: Lu20160062;
Drug Ad Approval No.: Lu20160062;
Application: Internal Medicine;
Usage Mode: For external use;
Suitable for: Elderly, Children, Adult;
State: Solid;
Shape: Powder;
Type: Organic Chemicals;
Pharmaceutical Technology: Chemical Synthesis;
Drug Reg./Approval No.: Lu20160062;
Drug Ad Approval No.: Lu20160062;
Application: Internal Medicine;
Usage Mode: For external use;
Suitable for: Elderly, Children, Adult;
State: Liquid;
Shape: Liquid;
Type: Organic Chemicals;
Pharmaceutical Technology: Chemical Synthesis;
Drug Reg./Approval No.: Lu20160062;
Drug Ad Approval No.: Lu20160062;
Application: Internal Medicine;
Usage Mode: For external use;
Suitable for: Elderly, Children, Adult;
State: Liquid;
Shape: Liquid;
Type: Organic Chemicals;
Pharmaceutical Technology: Chemical Synthesis;
Drug Reg./Approval No.: Lu20160062;
Drug Ad Approval No.: Lu20160062;
Supplier Name

Anhui Medipharm Co., Ltd.

Diamond Member Audited Supplier

REYOUNG PHARMACEUTICAL CO., LTD.

Diamond Member Audited Supplier

REYOUNG PHARMACEUTICAL CO., LTD.

Diamond Member Audited Supplier

REYOUNG PHARMACEUTICAL CO., LTD.

Diamond Member Audited Supplier

REYOUNG PHARMACEUTICAL CO., LTD.

Diamond Member Audited Supplier